HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 24 Hours

×
25 articles summarized · Last updated: v1299
You are viewing an older version. View latest →

Last updated: June 5, 2026, 2:30 PM ET

Fundraising Momentum

TJC launches seventh flagship with a $8.5bn target, extending its Resolute Fund VII focus on North‑American mid‑ and upper‑mid‑market companies. The European‑based Norvestor closes flagship at €2bn after a three‑month sprint, raising €500 m more than its predecessor and underscoring continued investor appetite for regional buyout vehicles. Across the Atlantic, Advent and ADIA pull $2.43bn from Innio IPO, a gas‑engine maker whose shares jumped 23% on debut, illustrating how private‑equity sponsors are leveraging public markets to recycle capital into new opportunities.

Strategic Acquisitions

Mill Point moves into safety products by acquiring Total Safety Supplies & Solutions, a distributor that expands its industrial‑equipment footprint in the U.S. market. In the automotive sector, Mutares lines up Reed Capital for Walor Precision, a carve‑out that adds precision‑turned components to the French sponsor’s portfolio. Meanwhile, Guardian snaps up E2 Consulting to bolster its utility‑infrastructure services platform, indicating a trend toward consolidating niche engineering firms under larger PE umbrellas.

Consumer Finance Expansion

CPP Investments ups its Affirm forward‑flow commitment to $1.7bn with an option to reach $2.2bn, a move that underpins roughly $8bn of consumer‑loan originations and signals confidence in the fintech lender’s balance‑sheet growth. In parallel, Allianz GI nears a $467 m deal for UOB Asset Management, edging out rivals KKR and Amundi and diversifying its exposure to Asian asset‑management fees as the region’s wealth pool swells.

Healthcare and Specialty Care

Warburg Pincus joins other firms targeting substance‑use assets as outpatient radiology demand fuels Kain Capital’s investment in Rad X, reflecting a broader shift toward high‑margin, recurring‑revenue health‑service models. Oxford Bio Medica’s CEO keeps the door open for EQT after rejecting its approach, suggesting the FTSE 250 cell‑and‑gene therapy specialist may entertain a take‑private offer if valuation aligns with its growth trajectory.

Exit Activity and Market Sentiment

Apollo withdraws its $2bn Bodycote bid amid rising fraud concerns in M&A, highlighting heightened diligence standards in large‑scale transactions. Conversely, Blackstone‑backed Liftoff tops $4.18bn valuation on Nasdaq, its shares climbing about 9% in the debut, showcasing how sponsor‑owned ad‑tech firms can capture premium public‑market pricing. These contrasting outcomes illustrate a market where sponsors balance aggressive growth exits with cautious deal‑making in a landscape of intensified regulatory and reputational scrutiny.